Decline in number of elevated blood CD3+ CD56+ NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy

American Journal of Reproductive Immunology

Volumn 58, Issue 5, 2007, Pages 447-459

  van den Heuvel, Marianne J ^a   Peralta, Crystal G ^a   Hatta, Kota ^a   Han, Victor K ^a   Clark, David A ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Flow cytometry; IVIG; NKT cells; Recurrent implantation failure; Recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; CD3 ANTIGEN; CD56 ANTIGEN; HEPARIN; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEMALE INFERTILITY; FLOW CYTOMETRY; HUMAN; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOID CELL; MENSTRUAL CYCLE; NATURAL KILLER T CELL; OBSERVATIONAL STUDY; PREDICTION; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD3; ANTIGENS, CD56; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFERTILITY, FEMALE; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME;

EID: 35148882676     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00529.x     Document Type: Article

References (59)

1. Clark DA: Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? J Assist Reprod Genet 2003; 20: 63-72.
2. Roberts CJ, Lowe CR: Where have all the conceptions gone? Lancet 1975; i: 498-499.
3. Kutteh WH, Triplett DA: Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 2006; 24: 54-66.
4. Kutteh WH, Ermel LD: A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35: 402-407.
5. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361: 901-908.
6. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
7. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N: Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21: 2216-2222.
8. Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J: Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005; 83: 684-690.
9. Carrington B, SacPs G, Regan L: Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17: 591-597.
10. Brigham SA, Conlon C, Farquharson RG: A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14: 2868-2871.
11. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345: 1340-1342.
12. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33: 40-46.
13. Matsubayashi H, Hosaka T, Sugiyama Y, Suzuki T, Arai T, Kondo A, Sugi T, Izumi S, Makino T: Increased natural killer-cell activity is associated with infertile women. Am J Reprod Immunol 2001; 46: 318-322.
14. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D: Granulated lymphocytes in human endometrium: Histochemical and immunohistochemical studies. Hum Reprod 1991; 6: 791-798.
15. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-4034.
16. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Sakuragi N, Fujimoto S: High NK cell activity in early pregnancy correlates with subsequent abortion with normal chromosomes in women with recurrent abortion. Am J Reprod Immunol 2001; 46: 132-136.
17. Moffett A, Regan L, Braude P: Natural killer cells, miscarriage, and infertility. BMJ 2004; 329: 1283-1285.
18. Thum MY, Bhaskaran S, Bansal AS, Shehata H, Ford B, Sumar N, Abdalla HI: Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod 2005; 20: 1272-1276.
19. Rai R, Sacks G, Trew G: Natural killer cells and reproductive failure -theory, practice and prejudice. Hum Reprod 2005; 20: 1123-1126.
20. Shakhar K, Ben Eliyahu S, Loewenthal R, Rosenne E, Carp H: Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage. Fertil Steril 2003; 80: 368-375.
21. Shakhar K, Rosenne E, Loewenthal R, Shakhar G, Carp H, Ben Eliyahu S: High NK cell activity in recurrent miscarriage: What are we really measuring? Hum Reprod 2006; 21: 2421-2425.
22. Thum MY, Bhaskaran S, Abdalla HI, Ford B, Sumar N, Shehata H, Bansal AS: An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004; 19: 2395-2400.
23. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I: Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15: 1163-1169.
24. Clark DA, Coulam CB, Stricker RB: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23: 1-13.
25. Kronenberg M: Toward an understanding oP NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877-900.
26. Spada FM, Koezuka Y, Porcelli SA: CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998; 188: 1529-1534.
27. Bendelac A, Rivera MN, Park SH, Roark JH: Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu Rev Immunol 1997; 15: 535-562.
28. Lee PT, Benlagha K, Teyton L, Bendelac A: Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 2002; 195: 637-641.
29. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-1212.
30. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-1074.
31. Tsuda H, Sakai M, Michimata T, Tanebe K, Hayakawa S, Saito S: Characterization of NKT cells in human peripheral blood and decidual lymphocytes. Am J Reprod Immunol 2001; 45: 295-302.
32. Boyson JE, Rybalov B, Koopman LA, Exley M, Balk SP, Racke FK, Schatz F, Masch R, Wilson SB, Strominger JL: CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2002; 99: 13741-13746.
33. Clark DA, Merali FS, Hoskin DW, Steel-Norwood D, Arck PC, Croitoru K, Murgita RA, Hirte H: Decidua-associated suppressor cells in abortion-prone DBA/2-mated CBA/J mice that release bioactive transforming growth factor beta2-related immunosuppressive molecules express a bone marrow-derived natural suppressor cell marker and gamma delta T-cell receptor. Biol Reprod 1997; 56: 1351-1360.
34. Daya S, Gunby J, Porter F, Scott J, Clark DA: Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum Reprod Update 1999; 5: 475-482.
35. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M, Yamashita M, Nakayama T, Taniguchi M: Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci U S A 2000; 97: 740-744.
36. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, vander Ven K: Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83: 821-839.
37. Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L, Huppertz B: Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol 2004; 191: 2125-2131.
38. Clark DA, Yu G, Levy GA, Gorczynski RM: Procoagulants in fetus rejection: The role of the OX-2 (CD200) tolerance signal. Semin Immunol 2001; 13: 255-263.
39. Ferry BL, Sargent IL, Starkey PM, Redman CW: Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy decidua. Cell Immunol 1991; 132: 140-149.
40. Knackstedt M, Ding JW, Arck PC, Hertwig K, Coulam CB, August C, Lea R, Dudenhausen JW, Gorczynski RM, Levy GA, Clark DA: Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 2001; 46: 196-210.
41. Clark DA, Ding JW, Chaouat G, Coulam CB, August C, Levy GA: The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol 1999; 42: 37-43.
42. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001; 2: 64-68.
43. Thurman JM, Holers VM: The central role of the alternative complement pathway in human disease. J Immunol 2006; 176: 1305-1310.
44. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006; 203: 2165-2175.
45. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136: 4480-4486.
46. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
47. Moretta L, Moretta A: Killer immunoglobulin-like receptors. Curr Opin Immunol 2004; 16: 626-633.
48. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, Wilson SB, Luster AD: CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003; 171: 2571-2580.
49. Burdin N, Brossay L, Kronenberg M: Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 1999; 29: 2014-2025.
50. Joyee AG, Qiu H, Wang S, Fan Y, Bilenki L, Yang X: Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J Immunol 2007; 178: 1048-1058.
51. Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175: 4084-4090.
52. Shivakumar S, Tsokos GC, Datta SK: T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 1989; 143: 103-112.
53. Zeng D, Aee MK, Tung J, Brendolan A, Strober S: Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000; 164: 5000-5004.
54. Yamada H, Morikawa M, Furuta I, Kato EH, Shimada S, Iwabuchi K, Minakami H: Intravenous immunoglobulin treatment in women with recurrent abortions: Increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003; 49: 84-89.
55. Lin H, Nieda M, Rozenkov V, Nicol AJ: Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Exp Hematol 2006; 34: 289-295.
56. Perricone R, Di Muzio G, Perricone C, Giacomelli R, De Nardo D, Fontana L, De Carolis C: High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. Am J Reprod Immunol 2006; 55: 232-239.
57. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
58. + cells and recurrent spontaneous abortion. Am J Reprod Immunol 2007; (in press).
59. Hutton B, Sharma R, Fergusson DA, Tinmouth AA, Hebert PC, Jamieson J, Walker M: Use of intravenous immunoglobulin for treatment of recurrent miscarriage: A systematic review. BJOG 2007; 114: 134-142.